Confidentiality 8. Důvěrnost informací Sample Clauses

Confidentiality 8. Důvěrnost informací. (a) Performance of the Study by Institution and Principal Investigator in the manner contemplated by this Agreement will require that Institution and the Principal Investigator have access to information, which is proprietary and confidential to SPONSOR including, but not limited to, the Study, Study Drug, Biological Samples, Protocols, Investigator’s Brochures, CRFs and any other information or material pertaining to SPONSOR or the Study. Institution and the Principal Investigator each agree that all information communicated or provided by SPONSOR and/or its agents, including any information related to the Study provided under confidentiality prior to this Agreement, or developed by Institution, or any Study Data or Principal Investigator in the course of performing the services hereunder, is the exclusive property of SPONSOR and SPONSOR’s confidential information (“Sponsor Confidential Information”). Institution and the Principal Investigator shall ensure that SPONSOR’s Confidential Information (i) shall be kept strictly confidential by the Principal Investigator and any person connected with the services within the Study, (ii) shall not be disclosed to any third party without prior written consent of SPONSOR, and (iii) shall only be used for the sole purpose of performing the services hereunder. The Principal Investigator shall communicate the results of the services promptly to SPONSOR. The Principal Investigator agrees that performance of the Study on behalf of Institution hereunder shall be within the scope of, and governed by the terms of, this Agreement. a) Způsob, jakým bude Zdravotnické zařízení a Hlavní zkoušející Studii podle této Smlouvy provádět vyžaduje, aby Zdravotnické zařízení a Hlavní zkoušející měli přístup k informacím, které jsou vlastnictvím a důvěrným majetkem ZADAVATELE, mimo jiné včetně samotné Studie, Hodnoceného přípravku, biologických vzorků, protokolů, souborů informací pro zkoušejícího, CRF a jakýchkoli jiných informací nebo materiálů týkajících se ZADAVATELE nebo Studie. Zdravotnické zařízení a Hlavní zkoušející souhlasí s tím, že veškeré informace, které sdělí nebo poskytne ZADAVATEL a/nebo jeho zástupci, včetně jakýchkoli důvěrných informací před uzavřením této Smlouvy nebo informací vyvinutých Zdravotnickým zařízením v souvislostí se Studií nebo jakékoli údaje ze Studie nebo o Hlavním zkoušejícím v průběhu poskytování služeb podle této Smlouvy, jsou výhradním vlastnictvím ZADAVATELE a důvěrnými informacemi ZADAVATELE (dál...
AutoNDA by SimpleDocs

Related to Confidentiality 8. Důvěrnost informací

  • Confidentiality (a) Subject to Section 7.15(c), during the Term and for a period of three

  • Limitation of Liability No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

  • Term and Termination In any case, if not sooner terminated, this Agreement shall expire at the close of business on the effective date that the Offering is terminated. This Agreement may be terminated by either party (a) immediately upon notice to the other party in the event that the other party shall have materially failed to comply with any material provision of this Agreement or if any of the representations, warranties, covenants or agreements of such party contained herein shall not have been materially complied with and such failure to comply is not cured within ten (10) days after the date of such occurrence or (b) on 60 days’ written notice. In any event, this Agreement shall be deemed suspended during any period for which the Dealer Manager’s license or registration to act as a broker dealer shall be revoked or suspended by any federal, self-regulatory or state agency. In addition, the Dealer Manager, upon the expiration or termination of this Agreement, shall (a) promptly deposit any and all funds in its possession which were received from investors for the sale of Shares into the appropriate escrow account or, if the Minimum Offering has been reached, into such other account as the Company may designate; and (b) promptly deliver to the Company all records and documents in its possession which relate to the Offering which are not designated as dealer copies. The Dealer Manager, at its sole expense, may make and retain copies of all such records and documents required to be retained by the Dealer Manager pursuant to (i) Federal and state securities laws and the rules and regulations thereunder, (ii) the applicable rules of FINRA and (iii) the NASAA REIT Guidelines, but shall keep all such information confidential; provided, that, nothing contained in this Agreement shall prevent the Dealer Manager from disclosing any such information to any regulatory authority asserting jurisdiction over the Dealer Manager. The Dealer Manager shall use its reasonable best efforts to cooperate with the Company to accomplish any orderly transfer of management of the Offering to a party designated by the Company. Upon expiration or termination of this Agreement, the Company shall pay to the Dealer Manager all earned but unpaid compensation and reimbursement for all incurred, accountable compensation to which the Dealer Manager is or becomes entitled under Section 5 of this Agreement, including but not limited to any Distribution Fees, pursuant to the requirements of that Section 5 at such times as such amounts become payable pursuant to the terms of such Section 5 without acceleration; provided, however, that if the Minimum Offering is not reached prior to such expiration or termination, the Company shall not pay any such compensation and reimbursements to the Dealer Manager.

  • Entire Agreement This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter contained in this Agreement and supersedes all prior agreements, understandings and negotiations between the parties.

  • General Provisions In connection with any Registration Statement and any Prospectus required by this Agreement to permit the sale or resale of Transfer Restricted Securities (including, without limitation, any Registration Statement and the related Prospectus required to permit resales of Initial Securities by Broker-Dealers), each of the Company and the Guarantors shall:

  • Term of Agreement This Agreement shall continue in full force and effect until the tenth (10th) anniversary of Bank Closing; provided, that the provisions of Section 6.3 and 6.4 shall survive the expiration of the term of this Agreement; and provided further, that the receivership of the Failed Bank may be terminated prior to the expiration of the term of this Agreement, and in such event, the guaranty of the Corporation, as provided in and in accordance with the provisions of Section 12.7 shall be in effect for the remainder of the term of this Agreement. Expiration of the term of this Agreement shall not affect any claim or liability of any party with respect to any (i) amount which is owing at the time of such expiration, regardless of when such amount becomes payable, and (ii) breach of this Agreement occurring prior to such expiration, regardless of when such breach is discovered.

  • Dispute Resolution All or any disputes arising out or touching upon or in relation to the terms and conditions of this Agreement, including the interpretation and validity of the terms thereof and the respective rights and obligations of the Parties, shall be settled amicably by mutual discussion, failing which the same shall be settled through the adjudicating officer appointed under the Act.

  • AGREEMENT The parties agree as follows:

  • Termination This Agreement may be terminated at any time prior to the Closing:

  • Background 1.1. The “Work” is the research article, review article, letter, clinical trial study, report, article, or other copyright work, as identified in the Copyright Letter and further detailed in Schedule 1: Details of the Work (including such form of the copyright work submitted to Xxxxxxx Science for publication pursuant to clause 4, below), but excluding (except where context otherwise requires) any diagrams, figures or illustration specifically identified to Xxxxxxx Science pursuant to clause 3.2, below.

Time is Money Join Law Insider Premium to draft better contracts faster.